@article{article, title  = {{Standard versus modified ipilimumab, in combination with nivolumab, in advanced renal cell carcinoma: a randomized phase II trial (PRISM)}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/205491 }},

 year = {{2023}},

 month = {{11}},

 author = {{Vasudev NS and Ainsworth G and Brown S and Pickering L and Waddell T and Fife K and Griffiths R and Sharma A and Katona E and Howard H and Velikova G et al}},

 doi = {{10.1200/jco.23.00236}},

 journal = {{Journal of Clinical Oncology}},

 pages = {{JCO2300236}},

 note = {{Accessed on 2025/12/05}}}